Journal of Industrial Microbiology & Biotechnology · 1986 · 41 citations · 12 references
Life SciencesBiotechnologyMolecular GeneticsMetabolismMicrobial MetabolismMicrobial PhysiologyMetabolic Pathways In FermentationMicrobial Physiology In Fermentation
The new immunosuppressive agent cyclosporine (Cyclosporin A, Cy) is the most prominent member of a group of cyclic peptide fungal metabolites (cyclosporins) produced byTolypocladium inflatum in submerged fermentations. In the present study, kinetics and physiology of mycelial growth and Cy production byT. inflatum were examined. A new semi-synthetic medium was formulated, consisting of a single carbon/energy source, Bacto-peptone, potassium phosphate and potassium chloride. A wide variety of carbon sources supported growth and Cy production. 3% (w/v) sorbose gave the highest final Cy titer (105.5 mg/l), based on 10-day fermentations. The best specific Cy production was observed with 2% sorbose (14.3 mg Cy/g biomass) followed by 5%myo-inositol (13.4 mg Cy/g biomass). A feeding strategy consisting of sequential addition of two carbon sources such as sorbose and maltose was developed in order to reach higher volumetric production. Genetic studies were also conducted, focussing on the development of mutants for increased Cy production and for the synthesis of novel cyclosporins. In the course of these studies, viable protoplasts ofT. inflatum have been isolated and regenerated.
12
Effects of the new anti-lymphocytic peptide cyclosporin A in animals.
J. F. Borel, Camille Feurer, C. Magnée et al. · PubMed · 1977 · 711 citations
Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset
C. R. Stiller, John Dupré, Michael Gent et al. · Science · 1984 · 558 citations
Horst Malke · Zeitschrift für allgemeine Mikrobiologie · 1981 · 418 citations
Michael Dreyfuss, E. H�rri, H. Hofmann et al. · Applied Microbiology and Biotechnology · 1976 · 305 citations